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OBJECTIVES: Hunter syndrome (HS) is a rare X-linked progressive multi-systemic
lysosomal storage disease. The 55 item child and 68 item parent versions of the 8
domain HS-FOCUS questionnaire were used to monitor the safety and efficacy with
enzyme replacement therapy (ERT) in clinical trials. The objective was to validate
HS-FOCUS according to the FDA PRO Guidance. METHODS: HS-FOCUS data col-
lected in a placebo-controlled trial (53 weeks, plus 36 months extension) were used
to evaluate item performance, reliability, validity, and responsiveness. RESULTS:
Altogether, 55 children and 84 parents completed the HS-FOCUS at baseline and
follow up visits. High percentage of lowest item response ( 60%) and high average
inter-item correlations suggested that some items were less informative or redun-
dant. The internal consistency met the0.70 criteria for all domains in parents and
children, except the breathing domain in children. The test-retest reliability was
0.70 for Walking/Standing, School/Work, Activities, and Overall Function do-
mains in parents, and for Walking/Standing and Activities domains in children.
The construct validity correlating the HS-FOCUS with Childhood Health Assess-
ment Questionnaire (CHAQ) showed moderate to high correlations in related con-
cepts, especially in activity related domains. Correlations with lung function (FEV1)
ranged from -0.06 (School/Work) to -0.48 (Breathing). Significantly score differences
were found in most domains among tertiles based on overall-well being and pain
VAS. Responsiveness showed large effect sizes, especially for Sleep, Breathing and
School/work domains (0.50-1.07). CONCLUSIONS: Developing disease-specific
PROs for rare diseases is challenging due to the nature of the evidence base. This
study demonstrates HS-FOCUS to be a reliable, valid, and responsive instrument
which can be applied in clinical trials or disease registries. The questionnaire can
be streamlined by reducing item redundancy without compromising its validity.
Simultaneously, an item bank may be generated which could serve as a basis for
developing questionnaires for other mucopolysaccharidosis disorders.
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OBJECTIVES: The PedsQL™ Measurement Model is a modular approach to measur-
ing health-related quality of life (HRQOL) in healthy children and adolescents and
those with acute and chronic health conditions. Several Spanish versions for use in
different Spanish speaking countries were developed. The objectives of this study
were to compare these Spanish versions, quantify and qualify the differences and
conclude on the need (or not) for country-specific Spanish versions.METHODS:Our
study focused on the Teen form (13-18) and included the following steps: 1.Collec-
tion of the validated Spanish versions in collaboration with the author; 2.Identifi-
cation of the differences in items, and response scales; and 3. Coding of the differ-
ences as Cultural (C), Lexical (L), Idiomatic (I) and Syntactical (S). RESULTS: Six
validated Spanish versions were retrieved: Spanish for US, Spain, Argentina, Chile,
Mexico and Peru. Since it was the first translated, the US Spanish version served as
comparator. All versions showed differences. Spanish for Spain showed the high-
est number of differences (57), then Chile (47), Argentina (36), Peru (20) and Mexico
(18). None of the differences were cultural. In 65% of the cases, the divergences
were idiomatic. For instance, the expression “Se me hace difícil” (It is hard for me)
used in US Spanish was replaced in all corresponding items by “Me cuesta” (Liter-
ally “It costs me”) in Spain, Argentina and Chile. The time recall sentence and item
3 of the School Functioning Scale showed most of the differences. One of the
reasons could be the use of a very idiomatic form in the original US English version:
“I have trouble keeping up”. It should be noted that items of the Emotional Func-
tioning Scale showed very few differences. CONCLUSIONS: Numerous changes in
wording for idiomatic reasons indicating respondents preferences point to the
necessity of developing specific Spanish versions of the PedsQL™.
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OBJECTIVES: The individualised expectations of the patient will undoubtedly be
one of the major preoccupations in the next few decades to guarantee optimal
treatment through compliance. METHODS: A pragmatic, European cohort (France,
Italy, and Portugal) of 477 patients presenting with urinary disorders, evocative of
BPH, was followed-up over 6 months. A questionnaire regarding expectations was
handed out at the first consultation. RESULTS: A total of 441 patients were evalu-
ated. The symptom that 31,11% of patients wished to see improved with the high-
est priority were “getting up in the night to urinate”, then for 20%, “sensation of not
emptying the bladder after urinating . Amongst the symptoms that patients were
the least concerned about were the effort or force needed to start urinating for
26,80% of responders, then “size and force of the stream of urine for 15,38% and
the interruption of the flow of urine for 13,40%.“Getting up in the night” was the
principal complaint in all 3 countries (36,30% in France, 29 and 27,54% in Portugal
and Italy), whereas the effort or force needed to start urinating is the symptom
that preoccupies the patients the least in France and Italy, and the “size and force
of the stream of urine” preoccupies the Portuguese the least.Nearly 87% of the
Italians claimed that they would only be satisfied if they never had to get up in the
night again, (35% for the French, 67% for the Portuguese).Overall, 60% of the sub-
jects questioned said that they would be satisfied if they were “markedly”
improved. CONCLUSIONS: The expectation of patients in the treatment of BPH is
very important, and undoubtedly difficult to satisfy entirely. These results are
probably due to the fact that our population was composed of patients that had
been diagnosed recently.
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OBJECTIVES: The objective of the study was to assess the effect of changes in
health-related behaviours on academic achievement and on HRQOL of children
and adolescents aged 8 – 18 years in a 3 years follow-up study. METHODS: A rep-
resentative sample of Spanish children and adolescents aged 8-18 years participat-
ing in the KIDSCREEN follow-up study completed the self-administered HRQOL
questionnaire KIDSCREEN-27, and questions regarding smoking and drinking hab-
its (binge drinking), among others at baseline (2003) and 3 years after (2006). Aca-
demic achievement, a scale of the Child Health and Illness Profile (CHIP), was
collected at follow-up. Data on gender and family socio-economic status was also
collected. Multivariate linear regression analysis was performed to assess the in-
fluence of changes in health-related behaviours on academic achievement and
HRQOL controlling for socioeconomic and family factors. RESULTS: Response rate
at follow-up was 54% (n454). Twenty six percent of the sample reported ever use
of tobacco, while 4.6% reported to have started or to be a current regular smoker at
follow-up; 18% reported starting or increasing alcohol consumption, and 16.5% on
substance consumption (mainly cannabis). Preliminary multivariate analyses
show that becoming a current smoker during the follow-up period was associated
to worse Academic achievement among girls (beta coefficient-5.0; p 0.02); re-
porting ever drug consumption was associated with worse Psychological well-be-
ing among girls (beta -3.1; p0.04), and with worse Physical well-being among
boys (beta -5.9; p0.004), at the follow-up. CONCLUSIONS: Changes in health-
related behaviours are associated with worse outcome at 3 years of follow-up.
Future studies should analyse factors related to susceptibility for regular use of
tobacco and other drugs. Policy initiatives, and other factors should be taken into
account preventing tobacco and other substance use at these ages.
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OBJECTIVES: Studies often examine the impact of specific chronic conditions (CC)
in isolation or in conjunction with another specific CC. Our aims were to compare:
1) the effect of physical CCs (PCC) in addition to mental CCs (MCC) to the effect of
PCCs only; 2) the effect of MCCs in addition to PCCs to the effect of MCCs only; and
3) effects across country. METHODS: Data from the 2010 EU National Health and
Wellness Survey were used (N57,805; France, Germany, Italy, Spain, and the UK).
Respondents were categorized as: ‘Healthy’ (no mental or physical CC); ‘Physical’
(physician indicated 1 physical but no mental CCs); ‘Mental’ (physician indicated
1mental but no physical CCs); ‘Physical and Mental’ (1mental and 1 physical
CCs). Differences across groups were assessed using multivariate regression with
SF-12v2® Health Survey summary measures (PCS & MCS) as outcomes and control-
ling for age and gender. RESULTS: Relative to ‘Healthy’ respondents, the presence
of 1 PCC was associated with a significant decrement in both PCS (-3.04 to -5.18,
p.05) and MCS (-1.23 to -2.53, p.05). The presence of 1 mental condition was
also associated with decreased MCS (-7.10 to -13.30, p.05) and PCS (-1.23 to -2.53,
p.05). Interestingly, the impact of co-morbid conditions, physical or mental, var-
ied as a function of other existing conditions (physical or mental). The impact of
adding 1 PCC to an existing MCC was associated with a larger decrement in PCS
(-4.34 to -6.92, p.05) and MCS (-8.54 to -11.70, p.05) as compared to adding 1 PCC
to those who were healthy. Results were consistent across gender and country.
CONCLUSIONS: These findings (which are largely consistent an earlier US study)
highlight the complexity of managing patients with co- or multi-morbid CCs as the
measurable burden of CCs varies with the presence of other conditions.
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